Looking to publish in Blood and Lymphatic Cancer Targets and Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowBlood and Lymphatic Cancer: Targets and Therapy is an international, peer reviewed, open access journal focusing on blood and lymphatic cancer research, identification of therapeutic targets, and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for the cancer patient.
Looking to publish in Blood and Lymphatic Cancer Targets and Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Blood and Lymphatic Cancer Targets and Therapy accepts the following article types. Click on an article type to view submission instructions.
Reviews
Original Research Papers
Meta-Analyses
Basic Science
Clinical Studies
Epidemiological Studies
Case Reports
Invited Reviews
Guidelines
Extended Reports
Recent Publications
Short-Term Longitudinal Analysis of Gut Microbiota Dynamics During Anti-CD19 CAR-T Cell Therapy in Diffuse Large B-Cell Lymphoma Patients
Ziyuan Shen, Xing Xing, Kang Rong, Ziyang Geng, Ning Yang, Linyan Xu, Hongfeng Ge, Wei Sang
Exploring the Bone Marrow Microenvironment as a Therapeutic Barrier and Targetable Source of Crosstalk in Acute Myeloid Leukemia
Aleksandra Kolosova, Imogen Mould, Chris Pepper, Simon Mitchell, Andrea Pepper, Eleni Ladikou, Fabio Simoes
A Risk Model Using Refined Disease Risk Index and 1-Month NK-Cell Count for Relapse in Children and Adults with T-ALL/LBL After Myeloablative Umbilical Cord Blood Transplantation
Na Zhao, Rong Chi, Kaidi Song, Yue Wu, Bingbing Yan, Dongyao Wang, Baolin Tang, Xiaoyu Zhu
Venetoclax Plus Hypomethylating Agents for Treatment-Naïve Myelodysplastic Syndromes with Increased Blasts: A Prospective Multicenter Cohort Study
Na Zhao, Lijun Zhu, Xing Hu, Juan Tong, Hongfeng Ge, Li Ye, Xijun Zhu, Can Gai, Yuhu Feng, Lei Zhang, Li Wang, Guangyu Sun, Lei Xue, Xiaoyu Zhu, Changcheng Zheng
Enzymatic Laccase Nanoreactors Induce Apoptosis in MOLT-4-ALL Cells and Activate Prodrugs in a Synergetic Effect
Carlos Medrano-Villagómez, Elizabeth Loredo-García, Jahaziel Gasperin-Bulbarela, Rafael Vazquez-Duhalt
Frequently asked questions
How long does it take to publish?
48 days average from submission to first editorial decision; 25 days average from editorial acceptance to publication.
Reformat to Blood and Lymphatic Cancer Targets and Therapy using Livewrite PremiumIs a cover letter required?
A point-by-point covering letter is required when submitting a revised manuscript after first editorial review.
Reformat to Blood and Lymphatic Cancer Targets and Therapy using Livewrite PremiumWhat are the publication costs?
Article publishing charge: US$3565.00 / £2640.00 / €3170.00, payable upon acceptance. No submission charge. Eligible authors may receive waivers or discounts.
Reformat to Blood and Lymphatic Cancer Targets and Therapy using Livewrite Premium